Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation

Omidubicel (nicotinamide-expanded cord blood) is a potential alternative source for allogeneic hematopoietic cell transplantation (HCT) when an HLA-identical donor is lacking. A phase I/II trial with standalone omidubicel HCT showed rapid and robust neutrophil and platelet engraftment. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: de Koning, Coco, Tao, Weiyang, Lacna, Amelia, van Veghel, Karin, Horwitz, Mitchell E., Sanz, Guillermo, Jagasia, Madan H., Wagner, John E., Stiff, Patrick J., Hanna, Rabi, Cilloni, Daniela, Valcárcel, David, Peled, Tony, Galamidi Cohen, Einat, Goshen, Uri, Pandit, Aridaman, Lindemans, Caroline A., Jan Boelens, Jaap, Nierkens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563413/
https://www.ncbi.nlm.nih.gov/pubmed/34312498
http://dx.doi.org/10.1038/s41409-021-01417-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563413/
https://www.ncbi.nlm.nih.gov/pubmed/34312498
http://dx.doi.org/10.1038/s41409-021-01417-4

Ejemplares similares